Search for Clinical Trial Results
Isolated Growth Hormone Deficiency - 25 Studies Found
Status | Study |
Completed |
Study Name: An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) Condition: Adult Growth Hormone Deficiency Date: 2013-03-05 Interventions: Drug: Saizen® solution for injection (referred as Saizen®) Saizen® solution for injection |
Completed |
Study Name: Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2010-01-29 Interventions:
|
Completed |
Study Name: Online Surveillance of Treatment of Children With Growth Hormone Deficiency With ZOMACTON Condition: Growth Hormone Deficiency Date: 2011-06-01 Interventions: Other: Growth hormone Drug given by prescription |
Completed |
Study Name: A Study of Zomacton in Children With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2009-04-17 Interventions:
|
Withdrawn |
Study Name: Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton® Condition: Growth Hormone Deficiency Date: 2012-11-16 Interventions: Drug: Somatropin Somatropin powder and solvent for solution for injection |
Active, not recruiting |
Study Name: 304-C03/L3301n: Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2006-08-08 Interventions: Drug: growth hormone (Nutropin) growth hormone (Nutropin), 0.3mg/kg/week administered subcutaneously dai |
Recruiting |
Study Name: A Long-Term Safety Study of Somavaratan in Japanese Children With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2017-04-05 Interventions: Drug: Somavaratan All subjects will receive somavaratan 3.5 mg/kg twice monthly (every 15 days ± 2 |
Recruiting |
Study Name: Clinical Study of Pegylated Somatropin to Treat Children Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2016-09-19 Interventions: Drug: PEG-somatropin High dose group: PEG Somatropin 0.2 mg/kg/w, subcutaneous use, inject once a week, |
Completed |
Study Name: Evaluation of Efficacy and Safety of Recombinant Somatroipn in Patients With Growth Hormone Deficiency Condition: Growth Hormone Deficiency Date: 2016-01-19 Interventions:
|
Terminated |
Study Name: Study to Assess Safety and Tolerability in Adults With Growth Hormone-Deficiency (GHD) Condition: Growth Hormone Deficiency Date: 2015-03-30 Interventions:
|